Varenicline for Smoking Cessation in Heavy Drinking Smokers
Conditions
Heavy Drinking | Nicotine Dependence | Smoking
What is the purpose of this trial?
The purpose of this study is to determine whether extended pretreatment with varenicline (Chantix) is more efficacious for smoking cessation than standard pretreatment, how well varenicline is tolerated in heavy drinking smokers, and whether varenicline reduces alcohol consumption.
Participation Guidelines
- Age:
- 18 Years - 75 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Yale University - Dates:
- October 2008
- Last Updated:
- January 28, 2013
- Study HIC#:
- 0809004276
Clinicaltrials.gov ID: NCT00860028
